We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+11.85%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$41.8B
AUM Growth
+$1.48B
(+3.7%)
Cap. Flow
-$1.36B
Cap. Flow
% of AUM
-3.25%
Top 10 Holdings %
Top 10 Hldgs %
19.13%
Holding
1,140
New
93
Increased
265
Reduced
373
Closed
166
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chipotle Mexican Grill
CMG
|
+$197M |
| 2 |
Occidental Petroleum
OXY
|
+$124M |
| 3 |
Boeing
BA
|
+$111M |
| 4 |
argenx
ARGX
|
+$108M |
| 5 |
CMA
Comerica
CMA
|
+$100M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$349M |
| 2 |
Burlington
BURL
|
+$186M |
| 3 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$166M |
| 4 |
Textron
TXT
|
+$160M |
| 5 |
Honeywell
HON
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.51% |
| 2 | Healthcare | 18.38% |
| 3 | Financials | 16.37% |
| 4 | Industrials | 8.21% |
| 5 | Consumer Discretionary | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Amylyx Pharmaceuticals
AMLX
$2.45B
| $70.5M | 0.17% |
1,909,201
+559,201
| +41% | +$19.8M |
|
152
Air Products & Chemicals
APD
$66.1B
| $69.6M | 0.17% |
225,640
-300
| -0.1% | -$84.5K |
|
153
Zoetis
ZTS
$31.6B
| $69.5M | 0.17% |
474,024
-2,900
| -0.6% | -$429K |
|
154
Mettler-Toledo International
MTD
$28.7B
| $68.9M | 0.16% |
47,657
+24,700
| +108% | +$33.1M |
|
155
Noble Corp
NE
$6.44B
| $68.9M | 0.16% |
1,826,134
+949,229
| +108% | +$33.8M |
|
156
Starbucks
SBUX
$119B
| $68.7M | 0.16% |
692,709
-907,150
| -57% | -$85.6M |
|
|
EXE
157
Expand Energy Corp
EXE
$21.7B
| $68M | 0.16% |
720,812
-190,000
| -21% | -$18.8M |
|
158
Micron Technology
MU
$1.01T
| $67.4M | 0.16% |
1,348,930
-38,200
| -3% | -$2.09M |
|
159
Colgate-Palmolive
CL
$73.1B
| $67M | 0.16% |
849,934
+306,114
| +56% | +$23M |
|
160
CSX Corp
CSX
$93.5B
| $66.9M | 0.16% |
2,158,404
-137,832
| -6% | -$4.14M |
|
161
F5
FFIV
$23.6B
| $66.9M | 0.16% |
465,900
-46,800
| -9% | -$6.85M |
|
162
Humana
HUM
$43.7B
| $66M | 0.16% |
128,810
-100
| -0.1% | -$52.6K |
|
163
Allegion
ALLE
$14B
| $63.4M | 0.15% |
602,371
+162,900
| +37% | +$17M |
|
164
Crown Castle
CCI
$34B
| $63.1M | 0.15% |
464,964
+23,804
| +5% | +$3.22M |
|
165
Applied Materials
AMAT
$434B
| $62.9M | 0.15% |
646,001
-15,600
| -2% | -$1.5M |
|
166
Lennox International
LII
$15.4B
| $62.9M | 0.15% |
+262,766
| New | +$64.3M |
|
167
Biogen
BIIB
$30.6B
| $61.6M | 0.15% |
222,599
-25,200
| -10% | -$7.12M |
|
168
CME Group
CME
$94.6B
| $61.5M | 0.15% |
365,931
-300
| -0.1% | -$52.1K |
|
169
Bristol-Myers Squibb
BMY
$134B
| $61.4M | 0.15% |
853,766
-1,372,229
| -62% | -$103M |
|
|
VMW
170
DELISTED
VMware, Inc
VMW
| $60.4M | 0.14% |
491,755
-41,585
| -8% | -$4.8M |
|
171
Moderna
MRNA
$23.1B
| $60.4M | 0.14% |
336,016
+3,300
| +1% | +$540K |
|
172
Monster Beverage
MNST
$91.3B
| $59.6M | 0.14% |
1,173,964
-341,000
| -23% | -$16.5M |
|
173
Valaris
VAL
$5.42B
| $59.6M | 0.14% |
880,716
+752,947
| +589% | +$47M |
|
174
SLB Ltd
SLB
$75.1B
| $59.5M | 0.14% |
1,112,267
-467,600
| -30% | -$23.3M |
|
|
175
Textron
TXT
$15.3B
| $58.7M | 0.14% |
829,345
-2,358,397
| -74% | -$160M |
|
Similar funds
Adage Capital Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Adage Capital Partners held 1,140 positions worth $41.8B, up 3.7% from $40.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Adage Capital Partners withdrew a net $1.36B in Q4 2022, closing 166 positions and reducing 373 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $349M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in argenx worth $109M.
- Adage Capital Partners's largest Q4 2022 buy was argenx: 287,396 shares worth $109M.
- Adage Capital Partners added most to Chipotle Mexican Grill in Q4 2022, an estimated $197M increase.
- Adage Capital Partners's biggest Q4 2022 reduction was Burlington, cutting an estimated $186M.
- Adage Capital Partners fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $349M.
- Adage Capital Partners's ten largest holdings make up 19% of its $41.8B portfolio in Q4 2022.
- Adage Capital Partners opened 93 new positions and closed 166 in Q4 2022.
- Adage Capital Partners's portfolio value rose 3.7% quarter-over-quarter to $41.8B.
Based on Adage Capital Partners's 13F filing for Q4 2022, filed 14 Feb 2023.